Literature DB >> 23810384

Identification of primary polydipsia in a severe and persistent mental illness outpatient population: a prospective observational study.

Felicia Iftene1, Christopher Bowie, Roumen Milev, Emily Hawken, Ewa Talikowska-Szymczak, Desmond Potopsingh, Samia Hanna, Jillian Mulroy, Dianne Groll, Richard Millson.   

Abstract

Studies to date have only investigated primary polydipsia in hospitalized psychiatric patient populations, where rates range from 3% to 25%. The objective of the present study was to determine the occurrence of primary polydipsia in a psychiatric outpatient population, and to determine the perceptions of outpatients with self-induced water intoxication regarding reasons for drinking excess fluids, health risks, and insight into their behavior. All 115 psychiatric outpatients from a Community Outreach Program in Kingston, Ontario, were invited to participate in this study. Of these, 89 (77.4%) were enrolled. Data collection included chart reviews, structured interviews, weight measurements, and urine collection. The incidence of primary polydipsia was found to be 15.7%. One-half of the polydipsic people presenting with medical complications suggestive for water intoxication had cigarette smoking as a strong correlate. There were interesting answers to the self-induced water intoxication questionnaire. These showed a lack of knowledge related to the normal quantity of fluids necessary daily and about healthy behaviors. Excessive drinking occurs in psychiatric patient populations outside of institutional/hospital settings. Patients have limited awareness of the severity and possible complications from their problem. Given the prevalence of polydipsia, more effort should be put into identifying and treating this problem.
Copyright © 2013 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Nicotine; Outpatients; Polydipsia; Psychosis; Schizophrenia

Mesh:

Year:  2013        PMID: 23810384     DOI: 10.1016/j.psychres.2013.04.011

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.

Authors:  Elena Martín-González; Ángeles Prados-Pardo; Santiago Mora; Pilar Flores; Margarita Moreno
Journal:  Psychopharmacology (Berl)       Date:  2018-01-08       Impact factor: 4.530

2.  The amphetamine sensitization model of schizophrenia symptoms and its effect on schedule-induced polydipsia in the rat.

Authors:  Emily R Hawken; Richard J Beninger
Journal:  Psychopharmacology (Berl)       Date:  2013-11-16       Impact factor: 4.530

Review 3.  To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance.

Authors:  Juliette A Brown; Hillary L Woodworth; Gina M Leinninger
Journal:  Front Syst Neurosci       Date:  2015-02-18

4.  Unusual circadian hypertension associated with polydipsia.

Authors:  Jürgen M Bohlender; Jürg Nussberger
Journal:  J Geriatr Cardiol       Date:  2016-11       Impact factor: 3.327

5.  Behavioral Biomarkers of Schizophrenia in High Drinker Rats: A Potential Endophenotype of Compulsive Neuropsychiatric Disorders.

Authors:  Silvia V Navarro; Roberto Alvarez; M Teresa Colomina; Fernando Sanchez-Santed; Pilar Flores; Margarita Moreno
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

6.  Converging Neurobiological Evidence In Primary Polydipsia Resembling Obsessive-Compulsive Disorder.

Authors:  Karthick Subramanian; Tess Maria Rajan; Vikas Menon; Ravi Philip Rajkumar
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

7.  Case Report: A Patient With Neuroleptic Malignant Syndrome, Water Intoxication and Hyponatremia Associated With Severe Cerebral Edema and Coma.

Authors:  Haruka Takenouchi; Takatoshi Anno; Yukiko Kimura; Fumiko Kawasaki; Ryo Shirai; Hideaki Kaneto; Katsumi Kurokawa; Koichi Tomoda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.